SUCCESS RATES OF TAMSULOSIN AND DUTASTERIDE AS MEDICAL THERAPY BASED ON IPSS IN SYMPTOMATIC BPH PATIENTS IN ARIFIN ACHMAD HOSPITAL PEKANBARU RIAU

SUCCESS RATES OF TAMSULOSIN AND DUTASTERIDE AS MEDICAL THERAPY BASED ON IPSS IN SYMPTOMATIC BPH PATIENTS IN ARIFIN ACHMAD HOSPITAL PEKANBARU RIAU

Objective: To evaluate the success rates of tamsulosin and dutasteride as medical therapy based on international prostate symptom score (IPSS) in symptomatic benign prostatic hyperplasia (BPH) patients. Materials & Methods: We reviewed medical records of the symptomatic BPH patients in Arifin Ac...

Full description

Bibliographic Details
Main Author:	Zuhirman Zamzami
Format:	Article
Language:	English
Published:	IKATAN AHLI UROLOGI INDONESIA 2018-07-01
Series:	Jurnal Urologi Indonesia
Subjects:	Benign prostatic hyperplasia international prostate symptom score medical therapy
Online Access:	http://juri.urologi.or.id/juri/article/view/410

Similar Items

CHARACTERISTICS OF TESTICULAR TORSION IN ARIFIN ACHMAD REGIONAL GENERAL HOSPITAL, PEKANBARU, RIAU PROVINCE, INDONESIA
by: Zuhirman Zamzami, et al.
Published: (2018-03-01)

Correlation between Initial International Prostate Symptom Score (IPSS) and Complications of Benign Prostatic Hyperplasia
by: Santapon Chamnarnprai, et al.
Published: (2023-07-01)

Combination therapy with Tamsulosin plus Dutasteride Versus Tamsulosin in Benign Prostatic Hyperplasia: a Systematic review & Meta-analysis
by: Behnam Amani, et al.
Published: (2023-02-01)

Effectiveness of tadalafil and tamsulosin combination in benign prostatic hyperplasia: A prospective cohort study at a tertiary care center
by: Sudarsan S, et al.
Published: (2023-08-01)

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
by: J Miller, et al.
Published: (2009-06-01)

The relation between baseline PSA and symptomatic progression in Egyptian BPH patients receiving tamsulosin monotherapy: an exploratory multicentric prospective study
by: Mahmoud S. El-Adawy, et al.
Published: (2019-12-01)

Evaluation of intermittent tamsulosin in treating symptomatic patients with benign prostatic hyperplasia
by: Mohamed G Soliman, et al.
Published: (2023-01-01)

THE EFFECT OF TAMSULOSIN 0.4 MG ADMINISTRATION TOWARDS ALTERATION OF PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN BENIGN PROSTATIC HYPERPLASIA (BPH) PATIENTS IN PADANG CITY
by: Fadly Asril, et al.
Published: (2024-05-01)

ANALYSIS OF DIFFERENCES DEGREE OF SEVERITY AND QUALITY OF LIFE OF BPH DIABETES WITH BPH NON-DIABETES PATIENTS
by: Prayoga Triyadi Kurnia Putra, et al.
Published: (2019-07-01)

Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
by: Zhongbao Zhou, et al.
Published: (2019-03-01)

DIFFERENCES IN THE EFFECTIVENESS OF SELECTIVE ALPHA BLOCKER THERAPY COMBINED WITH 5-ALPHA REDUCTASE INHIBITOR ON IPSS VALUE OF BPH LUTS PATIENTS
by: Septa Surya Wahyudi, et al.
Published: (2020-07-01)

Effects of dutasteride and tamsulosin on penile morphology in a rodent model
by: Marcello H. A. Da Silva, et al.
Published: (2023-06-01)

RISK FACTORS OF TESTICULAR CANCER IN ARIFIN ACHMAD REGIONAL GENERAL HOSPITAL, PEKANBARU, RIAU PROVINCE, INDONESIA
by: Zuhirman Zamzami
Published: (2019-03-01)

THE INCIDENCE AND CORRELATION OF CHRONIC PROSTATITIS WITH PSA IN BPH PATIENT
by: Daniel Mahendra Krisna, et al.
Published: (2018-07-01)

The Effective Way in Answering the IPSS: Patients Themselves or with the Physician?
by: Hasan Turgut, et al.
Published: (2021-03-01)

BPH and prostate cancer risk
by: Saiful Miah, et al.
Published: (2014-01-01)

Urinary incontinence following surgery for BPH: the role of aging on the incidence of bladder dysfunction
by: Homero Bruschini, et al.
Published: (2011-06-01)

Impact of drug use on patient symptom score and quality of life in benign prostatic hyperplasia patients
by: Harshank Vishnubhai Patel, et al.
Published: (2022-01-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
by: Aulia Nur Fadila, et al.
Published: (2020-07-01)

THE EFFICACY OF DUTASTERIDE AND GREEN TEA TOWARDS BLEEDING ON BPH AFTER TURP: STUDY THEIR EFFECT ON HIF-1α EXPRESSION & HEMATOCRIT
by: Andry Irawan, et al.
Published: (2017-07-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

To determine the association of transabdominal sonographic findings of prostatic volume and post void residual urine with the severity of symptoms as per international prostate symptom score, in cases of benign prostate hypertrophy
by: Ranjit Singh Lahel, et al.
Published: (2024-01-01)

Outcome of Surgery for Benign Prostatic Hyperplasia-Is It Predictable?
by: Suhani, et al.
Published: (2013-12-01)

Comparison of alpha-blockers and antimuscarinic for the treatment of double-J stent-related lower urinary tract symptoms.
by: Rabeea Saleem, et al.
Published: (2021-12-01)

Serum Biochemical and Hematological Parameters in Dogs with Benign Prostatic Hyperplasia (BPH)
by: Zohreh khaki, et al.
Published: (2017-01-01)

Transurethral Resection of Prostate and Blood loss: Efficacy of Dutasteride in reducing perioperative blood loss.
by: Shakeel Haseeb uddin Siddique, et al.
Published: (2021-04-01)

Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01)

Evaluation of serum prolidase activity and oxidative stress markers in men with BPH and prostate cancer
by: Faruk Kucukdurmaz, et al.
Published: (2017-12-01)

Comparison of Visual Prostate Symptom Score and International Prostate Symptom Score in the evaluation of men with benign prostatic hyperplasia: A prospective study from an Indian population
by: Yogesh Taneja, et al.
Published: (2017-12-01)

Prospective observational study on the efficacy and tolerability of a complex of phytochemicals vs. dutasteride in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
by: Giuseppe Saitta, et al.
Published: (2024-10-01)

Relation of baseline prostate volume to improvement of lower urinary tract symptoms due to tamsulosin monotherapy in benign prostatic hyperplasia: An exploratory, multicenter, prospective study
by: Mahmoud Shoukry El-Adawy, et al.
Published: (2020-01-01)

The role of preoperative dutasteride in reducing bleeding during transurethral resection of the prostate: A systematic review and meta-analysis of randomized controlled trials
by: Yudhistira Pradnyan Kloping, et al.
Published: (2022-01-01)

THE CORRELATIONS AMONG COMPONENTS OF METABOLIC SYNDROME PSA AND PROSTATE VOLUME IN BPH PATIENTS
by: Yanuar Wicaksana Sumasta, et al.
Published: (2016-09-01)

Modified Benign Prostate Hyperplasia (BPH) Specific Quality of Life Scale and IPSS in Assessment of Quality of Life in Lower Urinary Tract Symptom Patients Due to BPH
by: DEBANSU SARKAR, et al.
Published: (2021-10-01)

Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events
by: Young Hwii Ko, et al.
Published: (2010-12-01)

A multi-center, randomized, open label, two-arm study to evaluate safety & efficacy of nutraceutical tablet as adjuvant when compared with standard of care in patients with benign prostatic hyperplasia
by: Suresh B. Patankar, et al.
Published: (2024-09-01)

Transurethral resection of the prostate for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: how much should be resected?
by: Alberto A. Antunes, et al.
Published: (2009-12-01)

Short-term effect of tamsulosin and finasteride monotherapy and their combination on nigerian men with benign prostatic hyperplasia
by: Benjamin O Odusanya, et al.
Published: (2017-01-01)

RELATIONSHIP OF PERIURETHRAL FIBROTIC IN BPH PATIENT WITH LUTS AND URINARY RETENTION
by: Zamroni Zamroni, et al.
Published: (2017-07-01)

Making shared decisions with older men selecting treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia (LUTS/BPH): a pilot randomized trial
by: Haidee Ngu, et al.
Published: (2022-10-01)